Fever myths and misconceptions: The beneficial effects of fever as a critical component of host defenses against infection

Heart and Lung: Journal of Acute and Critical Care

Volumn 41, Issue 1, 2012, Pages 99-101

  Cunha, Burke A ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; HUMORAL ANTIBODY;

ANTIMICROBIAL THERAPY; CHEMOTAXIS; CORE TEMPERATURE; CRITICALLY ILL PATIENT; FEVER; HOST RESISTANCE; HUMAN; HYPERPYREXIA; INFECTION; LETTER; MEDICAL RESEARCH; NEUROLOGIC DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL;

BODY TEMPERATURE; FEVER; HUMANS;

EID: 84455169621     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2011.07.002     Document Type: Letter

References (25)

1. Kiekkas P. Peak fever: helpful or harmful?. Heart Lung 2011, 40:270-273.
2. Schulman C.I., Namias N., Doherty J., Manning R.J., Li P., Elhaddad A., et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized prospective study. Surg Infect (Larchmt) 2005, 6:369-375.
3. Kluger M.J., Ringler D.H., Anver M.R. Fever and survival. Science 1975, 188:166-168.
4. Roberts N.J. Temperature and host defense. Microbiol Rev 1979, 251-259.
5. Roszkowski W., Szmigielski S., Janiak M., Wrembel J.K., Roszkowski K., Hryniewicz W. Effect of hyperthermia on rabbit macrophages. Immunobiology 1980, 157:122-131.
6. Roberts N.J., Sandberg K. Hyperthermia and human leukocyte function II: enhanced production and response to leukocyte migration inhibition factor (LIF). JImmunol 1979, 122:1990-1993.
7. Jampel H.D., Duff G.W., Gershon R.K., Atkins E., Durum S.K. Fever and immunoregulation. III: fever augments the primary invitro humoral responses. JExp Med 1983, 157:1229-1238.
8. Van Oss C.J., Absolom D.R., Moore L.L., Park B.H., Humbert J.R. Effect of temperature on the chemotaxis, phagocytic engulfment, digestion and O2 consumption of human polymorphonuclear leukocytes. JReticuloendothe Soc 1980, 27:561-565.
9. Kuhn L.R. Effect of elevation body temperature on Cryptococcus in mice. Proc Soc Exp Biol Med 1949, 71:341.
10. Mackowiak P.A. Direct effects of hypothermia on pathogenic micro-organisms: teleologic implications with regard to fever. Rev Infect Dis 1981, 3:508-520.
11. Graham M.H., Burrell C.J., Douglas R.M., Debelle P., Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. JInfect Dis 1990, 162:1277-1287.
12. Mackowiak P.A., Marling-Cason M., Cohen R.L. Effects of temperature on antimicrobial susceptibility of bacteria. JInfect Dis 1982, 145:550-553.
13. Mackowiak P.A. Fever: blessing or curse?. Ann Intern Med 1994, 120:1037-1040.
14. Barone J.E. Fever: fact and fiction. JTrauma 2009, 67:406-409.
15. Cunha B.A. Should fever be treated in sepsis?. The Sepsis Text 2002, 705-717. Kluwer Academic Publisher, London. J.L. Vincent, J. Carlet, S.M. Opal (Eds.).
16. Plaisance K.I., Mackowiak P.A. Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med 2000, 160:449-456.
17. Greisman L.A., Mackowiak P.A. Fever: beneficial and detrimental effects of antipyretics. Curr Opin Infect Dis 2002, 15:241-245.
18. Klein N.C., Cunha B.A. Treatment of fever. Infect Dis Clin North Am 1996, 10:211-216.
19. Sawari A.R., Mackowiak P.A. The pharmacologic consequences of fever. Infect Dis Clin North Am 1996, 10:21-32.
20. Ryan M., Levy M.M. Clinical review: fever in intensive care unit patients. Crit Care 2003, 7:221-225.
21. Cunha B.A. The clinical significance of fever patterns. Infect Dis Clin North Am 1996, 10:33-44.
22. Styrt B., Sugarman B. Antipyresis and fever. Arch Intern Med 1990, 150:1589-1597.
23. Albrecht R.F., Wass C.T., Lanier W.L. Occurrence of potentially detrimental temperature alterations in hospitalized patients at risk for brain injury. Mayo Clin Proc 1998, 73:629-635.
24. Badjatia N. Hyperthermia and fever control in brain injury. Crit Care Med 2009, 37:S250-S257.
25. Owens S.D., Gasper P.W. Hyperthermic therapy for HIV infection. Med Hypotheses 1995, 44:235-242.